Design of stable biologically active recombinant lutropin analogs.

Glycoprotein hormones are noncovalent heterodimers comprised of a common alpha subunit and a hormone-specific beta subunit. Secretion and biologic action of these hormones are dependent on the formation of the heterodimer. The human LH beta subunit is unique among the other beta subunits in that it assembles inefficiently with the alpha subunit. To bypass this rate-limiting step, we constructed the LH single chains where the carboxy terminus of beta was fused to the amino terminus of alpha subunit through a linker. Compared to the human LH heterodimer, the extent of secretion was greater for the tethers although the rate was dependent on the nature of the linker. The LH single chains were biologically active even though there was loss of recognition by a LH-specific monoclonal antibody. This suggests that receptor binding of the single chains is not impaired by changes in the heterodimeric configuration resulting from tethering the subunits. In addition, single chains exhibited a remarkably greater in vitro stability than the heterodimer, implying that these analogs will be useful as diagnostic reagents and that their purification will be facilitated.

Novel recombinant gonadotropins.

The gonadotropin hormones chorionic gonadotropin, luteinizing hormone and follicle-stimulating hormone are heterodimers that consist of a common alpha subunit noncovalently associated with a hormone-specific beta subunit. Site-directed mutagenesis and gene transfer techniques have been invaluable tools for elucidating structure-function determinants of these hormones. Here, we review how questions about the structural biology of these glycoprotein hormones have provided crucial information for creating analogs (agonists and antagonists) that can be used to treat infertility in the clinic. The ability to manipulate the protein structure of these hormones will enable the engineering of both long- and short-acting therapeutic agents.

Independent activities of FSH and LH structurally confined in a single polypeptide: selective modification of the relative potencies of the hormones.

The human glycoprotein hormones CG, LH, FSH, and TSH are heterodimers composed of a common alpha subunit noncovalently associated with a hormone-specific beta subunit. Recently, it was reported that a covalently fused triple-domain gonadotropin analog containing FSH beta, CG beta, and alpha subunits was dually active because it bound to both FSH and human CG (hCG)/LH receptors. However, it is not known whether both activities can be uncoupled from each other or whether they change in tandem when modifications are made in the molecule. To address this point, we constructed a triple-domain analog containing FSH beta, LH beta, and alpha subunits, and variants of this analog differing in the carboxyl-terminal region of LH beta. All of the analogs exhibited bifunctional action, i.e. they bound to both LH/hCG and human FSH receptors. FSH binding and signal transduction were similar for all variants and differed less than 2-fold from that of the heterodimer. In contrast, the triple-domain variants manifested distinct individual differences in LH activity. Binding affinity of the longest variant was 30-fold lower than that of the heterodimer. Shortening the length of the LH beta carboxyl-terminal region resulted in decreasing affinities between 210- and more than 480-fold. The potency of adenylate cyclase activation for LH/hCG also decreased as the carboxyl length of LH beta subunit decreased. Thus, while minimally affecting the FSH activity, truncating the carboxyl end of the LH beta subunit in the triple-domain analogs alters the alignment of the LH beta-alpha domains, presumably at the junction between the subunits, and perturbs epitopes required for receptor binding. These data imply that the relative potencies of the two gonadotropin components of a triple-domain structure are independent from each other and can be selectively modified. Because there is a strong rationale for FSH/LH combinations for clinical protocols and patients exhibit variations in metabolic responses in the ratio of FSH/LH, the ability to vary the individual activities represents a potential addition to the therapeutic repertoire for treating infertility.

Synergism between the cellulosome-integrating protein CipA and endoglucanase CelD of Clostridium thermocellum.

The cellulosome-integrating protein CipA of Clostridium thermocellum was produced from a recombinant clone of Escherichia coli and purified by cellulose affinity and anion exchange chromatography. Two active forms of C. thermocellum endoglucanase CelD were tested for binding and hydrolytic activity on Avicel in the presence and in the absence of CipA. One was 68 kDa CelD, which contains an intact dockerin domain. The other was 65 kDa CelD, in which the dockerin domain is partially deleted. CipA promoted quantitative binding of 68 kDa CelD to Avicel and enhanced its Avicelase activity by at least ten-fold. By contrast, CipA had no effect on the activity nor on the cellulose-binding affinity of the truncated 65 kDa form. These results show that interaction between CipA and the catalytic component CelD is needed for the degradation of cellulose and confirm that the interaction is mediated by the dockerin domain of CelD.

Purification and characterisation of a beta-D-xylosidase from the anaerobic rumen fungus Neocallimastix frontalis.

A beta-D-xylosidase from the anaerobic rumen fungus Neocallimastix frontalis was purified by anion-exchange and gel filtration chromatography. The enzyme was isoelectrically homogeneous and had an isoelectric point of pH 4.6. The apparent molecular mass calculated by gel filtration was 150,000 Da. Under denaturing conditions, the enzyme appeared as a dimer composed of two polypeptides with molecular masses of 83,000 and 53,000 Da. The pH and temperature optimum were 6.4 and 37 degrees C, respectively: the activity was very sensitive to temperature. The enzyme was inhibited by copper, silver and zinc ions, EDTA and SDS, and was stimulated by calcium and magnesium ions. It was competitively inhibited by D-xylose with an apparent Ki of 3.98 mM. The beta-D-xylosidase exhibited hydrolytic activity on xylobiose and xylo-oligosaccharides of dp up to 7: the specific activities and maximum velocities decreased as the chain length increased. Analysis of the products of hydrolysis by HPLC indicated a typical exo-action. A mixture of beta-D-xylosidase and a xylanase acted synergistically in producing high reducing sugar values, using a xylan from oat spelts.

Hydrolysis of oligosaccharides of the ß-(1→4)-linked D-xylose series by an endo(1→4)-ß-D-xylanase from the anaerobic rumen fungus Neocallimastix frontalis.

An endo-(1→4)-ß-D-xylanase from Neocallimastix frontalis was purified by anion-exchange chromatography. The enzyme had an apparent molecular mass of 30 kDa on SDS-PAGE and exhibited maximum activity at 50°C and at pH values between 6.0 and 6.6. Kinetic studies on the hydrolysis of xylo-oligosaccharides, ranging from xylobiose to xylodecaose, showed that xylohexaose and xyloheptaose were the preferred substrates for the enzyme and that xylobiose, xylotriose and xylotetraose were not hydrolysed. Xylose was not a product of the hydrolysis of any of the xylo-oligosaccharide substrates tested. The enzyme appeared to have a strong preference for the hydrolysis of the internal glycosidic bonds of the oligosaccharides, which is typical of endo-(1→4)-ß-D-xylanase activity, but it differed from other fungal endo-(1→4)-ß-D-xylanases in that it had uniform action on the various internal linkages in the xylo-oligosaccharides.

Mode of action, kinetic properties and physicochemical characterization of two different domains of a bifunctional (1-->4)-beta-D-xylanase from Ruminococcus flavefaciens expressed separately in Escherichia coli.

Two catalytic domains, A and C, of xylanase A (XYLA) from Ruminococcus flavefaciens were expressed separately as truncated gene products from lacZ fusions in Escherichia coli. The fusion products, referred to respectively as XYLA-A1 and XYLA-C2, were purified to homogeneity by anion-exchange chromatography and chromatofocusing. XYLA-A1 was isoelectric at pH 5.0 and had a molecular mass of 30 kDa, whereas XYLA-C2 had a pI of 5.4 and a molecular mass of 44 kDa. The catalytic activity shown by both domains was optimal at 50 degrees C, but XYLA-A1 was more sensitive than XYLA-C2 to temperatures higher than the optimum. XYLA-A1 showed a higher sensitivity to pH than XYLA-C2. The enzyme activity of both domains was completely inactivated in the presence of copper or silver ions and partially inactivated by iron or zinc ions. Neither domain was active on xylo-oligosaccharides shorter than xylopentaose: the rate of degradation of longer xylo-oligosaccharides (degree of polymerization 5-10) increased as the chain length increased. Analysis of the products of hydrolysis of xylo-oligosaccharides and xylan (arabinoxylan) polysaccharide showed that the two domains differed in their modes of action: xylobiose was the shortest product of the hydrolysis. With oat spelt xylan as substrate, XYLA-A1 activity was apparently restricted to regions where xylopyranosyl residues did not carry arabinofuranosyl substituents, whereas XYLA-C2 was able to release hetero-oligosaccharides carrying arabinofuranosyl residues. Neither domain was able to release arabinose from oat spelt xylan.